Pax6基因轉(zhuǎn)錄本對HLE-B3細(xì)胞生物學(xué)功能調(diào)控的實(shí)驗(yàn)研究
本文選題:后發(fā)障 切入點(diǎn):Pax6基因 出處:《天津醫(yī)科大學(xué)》2012年博士論文 論文類型:學(xué)位論文
【摘要】:目的:1.建立大鼠后囊膜渾濁模型并測定Pax6轉(zhuǎn)錄本的表達(dá)變化。2.在HLE-B3細(xì)胞系通過敲減及回復(fù)表達(dá)Pax6轉(zhuǎn)錄本,觀察其對B3細(xì)胞的影響。3.利用基因芯片技術(shù)進(jìn)行全基因表達(dá)譜檢測觀察隨著Pax6轉(zhuǎn)錄本表達(dá)變化對下游基因的影響。方法:1.32只大鼠隨機(jī)分組右眼行ECLE,分別取手術(shù)后不同時(shí)間點(diǎn)的大鼠后囊膜組織,通過Real-time PCR測定后囊膜上Pax6基因轉(zhuǎn)錄本的表達(dá)水平。2.利用半定量PCR測定了人HLEB3細(xì)胞中Pax6的水平,構(gòu)建靶向Pax6的shRNA慢病毒載體,應(yīng)用shRNA干擾慢病毒感染B3細(xì)胞,觀察Pax6基因敲減后對B3細(xì)胞活力增殖的影響。3.構(gòu)建分別表達(dá)Pax6基因兩個(gè)轉(zhuǎn)錄本的慢病毒載體,在Pax6敲減后的細(xì)胞中進(jìn)行回復(fù)表達(dá),研究兩個(gè)轉(zhuǎn)錄本對B3細(xì)胞活力增殖的影響。4.利用上述shRNA干擾后及分別回復(fù)轉(zhuǎn)錄本1或轉(zhuǎn)錄本2,分別抽提RNA,再用Agilent 4X44K人類全基因表達(dá)譜芯片進(jìn)行檢測,分析Pax6基因變化對下游基因的影響及2個(gè)轉(zhuǎn)錄本的功能差異。結(jié)果:1.成功復(fù)制了大鼠后發(fā)障模型,構(gòu)建了大鼠Pax6基因的質(zhì)粒并進(jìn)行測序,獲得大鼠Pax6兩個(gè)轉(zhuǎn)錄本的序列。檢測Pax6兩個(gè)轉(zhuǎn)錄本的表達(dá),在手術(shù)后7天,Pax6兩種轉(zhuǎn)錄本的表達(dá)均有所增加,在術(shù)后14天時(shí)又有一定程度的回復(fù),至28天時(shí)降至最低。兩種轉(zhuǎn)錄本的表達(dá)趨勢比較相似。2.成功構(gòu)建了 Pax6 shRNA重組慢病毒載體,抑制Pax6基因表達(dá)后,B3細(xì)胞凋亡的數(shù)目成倍增加。3.敲減Pax6基因的表達(dá)水平后,單獨(dú)回復(fù)表達(dá)其中一個(gè)Pax6轉(zhuǎn)錄本,不但不能逆轉(zhuǎn)敲減Pax6造成的細(xì)胞活力下降、增殖減緩,反而加重了這種變化。特別是回復(fù)表達(dá)轉(zhuǎn)錄本2,導(dǎo)致了更明顯的細(xì)胞活力下降和增殖減緩,并且凋亡細(xì)胞數(shù)量也顯著的增加。4.基因芯片的結(jié)果顯示Pax6基因被敲減后,有224個(gè)基因表達(dá)被上調(diào),144個(gè)基因表達(dá)被下調(diào);RNAi的同時(shí)回復(fù)轉(zhuǎn)錄本1的表達(dá),引起758個(gè)基因表達(dá)上調(diào)和211個(gè)基因表達(dá)下調(diào);RNAi的同時(shí)回復(fù)轉(zhuǎn)錄本2的表達(dá),引起2033個(gè)基因表達(dá)上調(diào)和617個(gè)基因表達(dá)下調(diào)。回復(fù)表達(dá)所引起的基因表達(dá)的變化要更加明顯,尤其是2號轉(zhuǎn)錄本。結(jié)論:1.大鼠后發(fā)障模型Pax6基因的表達(dá)存在變化,而且在術(shù)后即刻、7d、14d、28d表達(dá)量有規(guī)律性改變,兩種轉(zhuǎn)錄本的表達(dá)趨勢比較一致。2.Pax6基因表達(dá)下調(diào)、在Pax6基因下調(diào)后單獨(dú)上調(diào)轉(zhuǎn)錄本1或轉(zhuǎn)錄本2的表達(dá),都表現(xiàn)出一致的抑制細(xì)胞增殖,凋亡增加,但程度上是有差異的。3.基因芯片結(jié)果顯示:Pax6兩個(gè)轉(zhuǎn)錄本的回復(fù)表達(dá),比Pax6的基因敲減,引起了更多與細(xì)胞周期和凋亡相關(guān)的基因表達(dá)的變化,包括WNT、p53信號通路的一些基因和Caspase相關(guān)的基因。
[Abstract]:Objective 1. To establish a rat model of posterior capsule opacification and to determine the expression of Pax6 transcripts. 2. To express Pax6 transcripts by knockdown and response in HLE-B3 cell lines. To observe its effect on B3 cells. 3. To observe the effect of Pax6 transcripts on downstream genes with the change of Pax6 transcripts. Methods one hundred and thirty-two rats were randomly divided into right eyes and treated with ECLE.After the operation, the whole gene expression profile was detected. The posterior capsule tissue of rats at different time points, The expression level of Pax6 gene transcripts on the posterior capsule was determined by Real-time PCR. 2. The Pax6 level in human HLEB3 cells was determined by semi-quantitative PCR. ShRNA lentivirus vector targeting Pax6 was constructed, and Lentivirus was infected by shRNA interfering lentivirus in B3 cells. To observe the effect of Pax6 knockout on the proliferation of B3 cells. 3. To construct the lentivirus vector expressing two transcripts of Pax6 gene, and to express them in the cells after Pax6 knockout. To study the effect of two transcripts on the proliferation of B3 cells. (4) by using the shRNA interference and reverting transcripts 1 or 2 respectively, RNAs were extracted separately, and then detected by Agilent 4X44K whole gene expression microarray. The effects of Pax6 gene changes on downstream genes and the functional differences of two transcripts were analyzed. Results: 1. The rat model of posterior barrier was successfully established, and the plasmid of rat Pax6 gene was constructed and sequenced. We obtained the sequence of two transcripts of rat Pax6. The expression of two transcripts of Pax6 increased 7 days after operation and returned to a certain extent at 14 days after operation. The expression trend of the two transcripts was similar. 2. The recombinant lentivirus vector of Pax6 shRNA was successfully constructed, and the number of apoptosis of B3 cells increased exponentially after inhibiting the expression of Pax6 gene. After knocking down the expression level of Pax6 gene, the expression level of Pax6 gene was reduced. The expression of one of the Pax6 transcripts alone could not reverse the decrease in cell viability caused by Pax6 knockout, and the proliferation of cells was slowed down. In particular, the response to transcription 2 resulted in a more significant decrease in cell viability and slower proliferation, and a significant increase in the number of apoptotic cells. The results of the microarray showed that the Pax6 gene was knocked out. The expression of 224 genes was up-regulated, 144 genes were down-regulated and the expression of transcription 1 was restored simultaneously, which resulted in 758 gene expression upregulation and 211 gene expression down-regulation. 2 033 genes were up-regulated and 617 genes were down-regulated. The changes of gene expression induced by reverse-expression were more obvious, especially in transcription number 2. Conclusion: 1. The expression of Pax6 gene in rat model of posterior impairment is changed. The expression of Pax6 gene was down-regulated at 14d ~ 28d after Pax6 down-regulation. After down-regulation of Pax6 gene, the expression of transcription 1 or transcription 2 was upregulated. Both showed consistent inhibition of cell proliferation and increased apoptosis, but the degree of apoptosis was different. The results of gene chip showed that the two transcripts of the two transcripts of Pax6 were less expressed than those of Pax6 gene knockout. It has caused more changes in cell cycle and apoptosis related gene expression, including some genes in the p53 signaling pathway and Caspase related genes.
【學(xué)位授予單位】:天津醫(yī)科大學(xué)
【學(xué)位級別】:博士
【學(xué)位授予年份】:2012
【分類號】:R776.1
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李黎;5′外顯子及多聚嘌呤化位點(diǎn)的變換可使單拷貝基因產(chǎn)生多種轉(zhuǎn)錄本[J];國外醫(yī)學(xué)(分子生物學(xué)分冊);1994年01期
2 史常永;清·嘉慶11年(1806年)朱潤轉(zhuǎn)錄本,薛雪撰,1卷。[J];山西中醫(yī)學(xué)院學(xué)報(bào);2003年02期
3 符爽;孫開來;富偉能;;MYCT1新轉(zhuǎn)錄本的克隆與表達(dá)分析[J];中國醫(yī)科大學(xué)學(xué)報(bào);2014年05期
4 邵康,赫捷,程邦昌,肖智雄,張德超,黃微,張翠艷,周芳,熊美華,唐槐靜,石素勝,姆巴東;RASSF1基因不同轉(zhuǎn)錄本在肺癌組織中的轉(zhuǎn)錄表達(dá)及臨床意義[J];中華腫瘤雜志;2003年02期
5 林江 ,錢軍 ,張永寧 ,季勇慧 ,吳朝陽 ,費(fèi)霞 ,王法春 ,唐華容 ,江云偉;應(yīng)用實(shí)時(shí)定量PCR技術(shù)檢測慢性粒細(xì)胞白血病患者p210~(bcr/abl)轉(zhuǎn)錄本的臨床意義[J];陜西醫(yī)學(xué)雜志;2004年12期
6 王旭;張帆;徐艷;吳秀麗;陳少華;楊力建;李,
本文編號:1608409
本文鏈接:http://sikaile.net/yixuelunwen/wuguanyixuelunwen/1608409.html